$0.54
+0.04 (+8.54%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+4,511.2% upside
Low Target
$15.48
Average Target
$24.85
High Target
$31.61
Current Price
$0.54
Current
$0.54
$0.54
Target
$24.85
$24.85
$15.48
$24.85 avg
$31.61
Scenario Analysis
Bear Case
$15.48
2,772.5%
Low target
Base Case
$24.85
+4,511.2%
Avg target
Bull Case
$31.61
+5,765.7%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$23.49
-97.7% from high
52-Week Low
$13.99
+-96.1% from low
Target vs 52W High
$24.85
+5.8% vs high
Next Earnings Report
Feb 19, 2026 · After Market Close
3d
until earnings
EPS Est: $-0.22
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |